CDTX - Cidara Therapeutics EPS misses by $0.02 beats on revenue November, 10 2021 04:42 PM Cidara Therapeutics Inc. Cidara Therapeutics (NASDAQ:CDTX): Q3 GAAP EPS of -$0.37 misses by $0.02. Revenue of $7.08M (+192.6% Y/Y) beats by $4.14M. Press Release For further details see: Cidara Therapeutics EPS misses by $0.02, beats on revenue